Prescribing a medication for a condition not described in the label approved by national regulatory bodies (in Switzerland, Swissmedic) is called "off-label" prescribing. Unlicensed drug use is common in all fields of medicine and may be encountered in therapeutic guidelines. The term does not imply improper nor illegal use, and may provide the only available treatment for "orphan" conditions, or for certain populations (children, pregnant women, very old patients). Off-label drug use should be based on sound scientific evidence of efficacy and safety. In Switzerland, patients need to be informed that health insurance coverage is not guaranteed with off-label use. The prescribing physician bears the responsibility of off-label use with the ...
Abstract Background Off-label use of (orphan) medicinal products for (rare) diseases is quite common...
The lack of specific drugs and labelling recommendations for the neonatal population is a long-stand...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
So-called ‘‘off label’ ’ and unlicensed prescribing refers to the use of medicines outside of the in...
Off-label use of drugs is widely known as unapproved use of approved drugs, and it can be perceived ...
INTRODUCTION Concern about off-label prescriptions, that is to say prescriptions of a drug for thera...
La prescription de médicament hors AMM est légitime quand elle s’appuie sur les connaissances médica...
The terms 'licensed', 'unlicensed', and 'off-label', often used in relation to marketing and prescri...
Approval of a drug for clinical use requires production of data on efficacy and safety through submi...
The use of off-label drugs may be defined as the utilization of drugs in conditions other than the o...
The off-label prescribing is multifaceted problem and affects the interests and scope of activitie...
International audienceObjectives Off-label drug prescribing is a public health and economic issue. T...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
Off label medicine refers to any medicine that is used to treat any ailment beyond of its approved /...
Abstract Background Off-label use of (orphan) medicinal products for (rare) diseases is quite common...
The lack of specific drugs and labelling recommendations for the neonatal population is a long-stand...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...
• Off-label prescribing is the prescription of a registered medicine for a use that is not included ...
So-called ‘‘off label’ ’ and unlicensed prescribing refers to the use of medicines outside of the in...
Off-label use of drugs is widely known as unapproved use of approved drugs, and it can be perceived ...
INTRODUCTION Concern about off-label prescriptions, that is to say prescriptions of a drug for thera...
La prescription de médicament hors AMM est légitime quand elle s’appuie sur les connaissances médica...
The terms 'licensed', 'unlicensed', and 'off-label', often used in relation to marketing and prescri...
Approval of a drug for clinical use requires production of data on efficacy and safety through submi...
The use of off-label drugs may be defined as the utilization of drugs in conditions other than the o...
The off-label prescribing is multifaceted problem and affects the interests and scope of activitie...
International audienceObjectives Off-label drug prescribing is a public health and economic issue. T...
European Union (EU) legislation on marketing authorisation of medicinal products aims to safeguard p...
Off label medicine refers to any medicine that is used to treat any ailment beyond of its approved /...
Abstract Background Off-label use of (orphan) medicinal products for (rare) diseases is quite common...
The lack of specific drugs and labelling recommendations for the neonatal population is a long-stand...
The current state of the Russian and foreign regulatory framework for off-label prescription of medi...